HCA Healthcare (HCA) Stock Forecast, Price Target & Predictions
HCA Stock Forecast
HCA Healthcare stock forecast is as follows: an average price target of $291.95 (represents a -24.75% downside from HCA’s last price of $387.98) and a rating consensus of 'Buy', based on 23 wall street analysts offering a 1-year stock forecast.
HCA Price Target
The average price target for HCA Healthcare (HCA) is $291.95 based on 1-year price targets from 23 Wall Street analysts in the past 3 months, with a price target range of $430.00 to $224.00. This represents a potential -24.75% downside from HCA's last price of $387.98.
HCA Analyst Ratings
According to 23 Wall Street analysts, HCA Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for HCA stock is 0 'Strong Buy' (0.00%), 17 'Buy' (73.91%), 6 'Hold' (26.09%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
HCA Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 19, 2024 | David MacDonald | Truist Financial | $430.00 | $373.77 | 15.04% | 10.83% |
| Jun 28, 2024 | Pito Chickering | Deutsche Bank | $375.00 | $335.04 | 11.93% | -3.35% |
| Jun 06, 2024 | Brian Tanquilut | Jefferies | $390.00 | $336.82 | 15.79% | 0.52% |
| Apr 29, 2024 | Ben Hendrix | RBC Capital | $329.00 | $311.07 | 5.76% | -15.20% |
| Apr 29, 2024 | Michael Wiederhorn | Oppenheimer | $345.00 | $306.69 | 12.49% | -11.08% |
| Apr 12, 2024 | Pito Chickering | Deutsche Bank | $359.00 | $327.25 | 9.70% | -7.47% |
| Apr 24, 2023 | Ann Hynes | Mizuho Securities | $298.00 | $285.91 | 4.23% | -23.19% |
| Apr 24, 2023 | Ben Hendrix | RBC Capital | $315.00 | $285.91 | 10.17% | -18.81% |
| Apr 24, 2023 | Michael Wiederhorn | Oppenheimer | $310.00 | $285.91 | 8.43% | -20.10% |
| Feb 08, 2023 | - | Goldman Sachs | $296.00 | $257.09 | 15.13% | -23.71% |
The latest HCA Healthcare stock forecast, released on Aug 19, 2024 by David MacDonald from Truist Financial, set a price target of $430.00, which represents a 15.04% increase from the stock price at the time of the forecast ($373.77), and a 10.83% increase from HCA last price ($387.98).
HCA Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 6 |
| Avg Price Target | $430.00 | $402.50 | $371.33 |
| Last Closing Price | $387.98 | $387.98 | $387.98 |
| Upside/Downside | 10.83% | 3.74% | -4.29% |
In the current month, the average price target of HCA Healthcare stock is $430.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 10.83% increase as opposed to HCA Healthcare's last price of $387.98. This month's average price target is up 6.83% compared to last quarter, and up 15.80% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 03, 2024 | Morgan Stanley | - | Equal-Weight | Initialise |
| Aug 23, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Jul 30, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Jul 25, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Jul 24, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Jul 24, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Jul 23, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
| Jul 14, 2024 | Bernstein | Market Perform | Market Perform | Hold |
| Jul 10, 2024 | Barclays | Overweight | Overweight | Hold |
| Jun 28, 2024 | Deutsche Bank | Buy | Buy | Hold |
HCA Healthcare's last stock rating was published by Morgan Stanley on Sep 03, 2024. The company Initialise its HCA rating from "null" to "Equal-Weight".
HCA Healthcare Financial Forecast
HCA Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | - | $14.95B | $15.06B | $15.28B | $14.44B | $13.98B | $14.29B | $13.31B | $11.07B | $12.86B | $13.52B | $12.69B |
| Avg Forecast | $20.66B | $19.46B | $19.42B | $19.25B | $19.48B | $18.47B | $18.41B | $18.24B | $18.53B | $17.50B | $17.05B | $16.81B | $16.51B | $15.82B | $15.63B | $15.27B | $15.63B | $15.00B | $14.72B | $14.75B | $15.35B | $14.53B | $13.61B | $13.63B | $13.99B | $12.85B | $10.09B | $13.06B | $13.36B | $12.50B |
| High Forecast | $21.00B | $19.78B | $19.74B | $19.56B | $19.80B | $18.76B | $18.71B | $18.54B | $18.83B | $17.66B | $17.33B | $17.08B | $16.78B | $15.96B | $15.89B | $15.52B | $15.88B | $15.24B | $14.72B | $14.98B | $15.59B | $14.76B | $13.83B | $13.85B | $14.21B | $13.05B | $10.25B | $13.27B | $13.57B | $12.70B |
| Low Forecast | $20.38B | $19.20B | $19.16B | $18.99B | $19.22B | $18.21B | $18.16B | $17.99B | $18.27B | $17.04B | $16.82B | $16.58B | $16.32B | $15.39B | $15.42B | $15.06B | $15.42B | $14.80B | $14.72B | $14.55B | $15.14B | $14.34B | $13.43B | $13.44B | $13.80B | $12.67B | $9.95B | $12.89B | $13.18B | $12.33B |
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 11 | 9 | 9 | 14 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.01% | 1.02% | 0.99% | 1.00% | - | 1.01% | 0.98% | 1.05% | 1.06% | 1.03% | 1.02% | 1.04% | 1.10% | 0.98% | 1.01% | 1.02% |
HCA Healthcare's average Quarter revenue forecast for Dec 23 based on 9 analysts is $16.51B, with a low forecast of $16.32B, and a high forecast of $16.78B. HCA's average Quarter revenue forecast represents a 1.85% increase compared to the company's last Quarter revenue of $16.21B (Sep 23).
HCA Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 11 | 9 | 9 | 14 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.88B | $3.06B | $3.17B | $3.18B | $2.90B | - | $2.94B | $3.52B | $4.07B | $3.00B | $2.90B | $2.85B | $1.96B | $2.50B | $1.79B | $2.54B | $1.92B |
| Avg Forecast | $4.13B | $3.89B | $3.88B | $3.84B | $3.89B | $3.69B | $3.68B | $3.64B | $3.70B | $3.49B | $3.40B | $3.44B | $3.30B | $3.16B | $3.12B | $3.13B | $3.12B | $3.96B | $2.94B | $2.85B | $3.61B | $3.60B | $1.86B | $2.19B | $2.44B | $2.29B | $2.01B | $2.01B | $2.54B | $1.83B |
| High Forecast | $4.19B | $3.95B | $3.94B | $3.91B | $3.95B | $3.75B | $3.74B | $3.70B | $3.76B | $3.53B | $3.46B | $4.13B | $3.35B | $3.19B | $3.17B | $3.76B | $3.17B | $4.75B | $2.94B | $3.42B | $4.33B | $4.32B | $2.24B | $2.63B | $2.93B | $2.75B | $2.05B | $2.41B | $3.04B | $2.20B |
| Low Forecast | $4.07B | $3.83B | $3.82B | $3.79B | $3.84B | $3.64B | $3.63B | $3.59B | $3.65B | $3.40B | $3.36B | $2.76B | $3.26B | $3.07B | $3.08B | $2.50B | $3.08B | $3.17B | $2.94B | $2.28B | $2.89B | $2.88B | $1.49B | $1.75B | $1.95B | $1.83B | $1.99B | $1.60B | $2.03B | $1.47B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.91% | 0.98% | 1.01% | 1.02% | 0.73% | - | 1.03% | 0.98% | 1.13% | 1.61% | 1.32% | 1.17% | 0.85% | 1.24% | 0.89% | 1.00% | 1.05% |
9 analysts predict HCA's average Quarter EBITDA for Dec 23 to be $3.30B, with a high of $3.35B and a low of $3.26B. This is 14.47% upper than HCA Healthcare's previous annual EBITDA (Sep 23) of $2.88B.
HCA Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 11 | 9 | 9 | 14 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | - | $1.27B | $2.00B | $2.27B | $1.45B | $1.42B | $1.43B | $668.00M | $1.08B | $581.00M | $1.07B | $612.00M |
| Avg Forecast | $2.12B | $1.56B | $1.78B | $1.71B | $1.93B | $1.47B | $1.64B | $1.54B | $1.75B | $1.29B | $1.30B | $1.59B | $1.33B | $1.05B | $1.12B | $1.44B | $1.26B | $2.21B | $991.54M | $1.31B | $1.86B | $2.01B | $901.10M | $1.08B | $1.22B | $783.17M | $9.98B | $649.22M | $1.07B | $583.27M |
| High Forecast | $2.17B | $1.59B | $1.82B | $1.74B | $1.97B | $1.51B | $1.68B | $1.57B | $1.79B | $1.35B | $1.33B | $1.90B | $1.42B | $1.14B | $1.15B | $1.73B | $1.29B | $2.65B | $991.54M | $1.57B | $2.23B | $2.41B | $1.08B | $1.29B | $1.46B | $939.81M | $11.98B | $779.07M | $1.29B | $699.92M |
| Low Forecast | $2.08B | $1.53B | $1.75B | $1.68B | $1.90B | $1.45B | $1.61B | $1.51B | $1.72B | $1.14B | $1.28B | $1.27B | $1.30B | $978.72M | $1.10B | $1.15B | $1.24B | $1.77B | $991.54M | $1.05B | $1.49B | $1.61B | $720.88M | $861.49M | $976.47M | $626.54M | $7.99B | $519.38M | $856.80M | $466.61M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.06% | 0.94% | 1.65% | 0.51% | - | 0.97% | 1.08% | 1.13% | 1.61% | 1.32% | 1.17% | 0.85% | 0.11% | 0.89% | 1.00% | 1.05% |
HCA Healthcare's average Quarter net income forecast for Dec 23 is $1.33B, with a range of $1.30B to $1.42B. HCA's average Quarter net income forecast represents a 23.53% increase compared to the company's last Quarter net income of $1.08B (Sep 23).
HCA Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 11 | 9 | 9 | 14 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $7.56B | $7.28B | $7.08B | $7.05B | $6.90B | - | $6.94B | $7.00B | $7.09B | $6.38B | $6.30B | $6.33B | $6.10B | $5.33B | $6.12B | $6.11B | $5.97B |
| Avg Forecast | $9.47B | $8.92B | $8.90B | $8.82B | $8.93B | $8.46B | $8.44B | $8.36B | $8.49B | $8.02B | $7.82B | $8.65B | $7.57B | $7.25B | $7.16B | $7.87B | $7.16B | $6.91B | $6.75B | $7.15B | $7.17B | $6.28B | $3.97B | $4.77B | $5.42B | $7.15B | $4.62B | $6.84B | $6.11B | $5.69B |
| High Forecast | $9.62B | $9.06B | $9.04B | $8.97B | $9.07B | $8.60B | $8.57B | $8.50B | $8.63B | $8.09B | $7.94B | $10.38B | $7.69B | $7.31B | $7.28B | $9.44B | $7.28B | $8.29B | $6.75B | $8.58B | $8.60B | $7.54B | $4.76B | $5.72B | $6.50B | $8.58B | $4.70B | $8.20B | $7.33B | $6.83B |
| Low Forecast | $9.34B | $8.80B | $8.78B | $8.70B | $8.81B | $8.35B | $8.32B | $8.25B | $8.37B | $7.81B | $7.71B | $6.92B | $7.48B | $7.05B | $7.07B | $6.29B | $7.07B | $5.53B | $6.75B | $5.72B | $5.74B | $5.02B | $3.17B | $3.81B | $4.33B | $5.72B | $4.56B | $5.47B | $4.88B | $4.55B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.02% | 0.90% | 0.98% | 1.00% | - | 0.97% | 0.98% | 1.13% | 1.61% | 1.32% | 1.17% | 0.85% | 1.15% | 0.89% | 1.00% | 1.05% |
HCA Healthcare's average Quarter SG&A projection for Dec 23 is $7.57B, based on 9 Wall Street analysts, with a range of $7.48B to $7.69B. The forecast indicates a 0.16% rise compared to HCA last annual SG&A of $7.56B (Sep 23).
HCA Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 11 | 9 | 9 | 14 | 4 | 4 | 7 | 4 | 4 | 3 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.97 | $4.34 | $4.92 | $7.50 | $3.99 | - | $4.26 | $6.56 | $7.24 | $4.49 | $4.26 | $4.20 | $1.97 | $3.19 | $1.72 | $3.16 | $1.80 |
| Avg Forecast | $8.03 | $5.89 | $6.74 | $6.46 | $7.32 | $5.58 | $6.21 | $5.82 | $6.63 | $4.90 | $4.93 | $5.06 | $5.05 | $3.98 | $4.25 | $3.91 | $4.79 | $3.88 | $3.70 | $4.26 | $4.52 | $4.06 | $3.16 | $3.32 | $3.57 | $2.29 | $-0.19 | $2.64 | $3.09 | $2.13 |
| High Forecast | $8.20 | $6.02 | $6.88 | $6.60 | $7.48 | $5.70 | $6.35 | $5.95 | $6.77 | $5.10 | $5.04 | $5.16 | $5.37 | $4.30 | $4.34 | $3.99 | $4.89 | $3.96 | $3.70 | $4.35 | $4.61 | $4.15 | $3.23 | $3.39 | $3.64 | $2.34 | $-0.19 | $2.69 | $3.16 | $2.17 |
| Low Forecast | $7.89 | $5.79 | $6.62 | $6.35 | $7.19 | $5.48 | $6.10 | $5.72 | $6.51 | $4.33 | $4.85 | $4.97 | $4.91 | $3.71 | $4.17 | $3.84 | $4.71 | $3.81 | $3.70 | $4.19 | $4.44 | $3.99 | $3.11 | $3.27 | $3.50 | $2.25 | $-0.20 | $2.59 | $3.04 | $2.09 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.02% | 1.26% | 1.57% | 1.03% | - | 1.00% | 1.45% | 1.78% | 1.42% | 1.28% | 1.18% | 0.86% | -16.42% | 0.65% | 1.02% | 0.85% |
According to 9 Wall Street analysts, HCA Healthcare's projected average Quarter EPS for Dec 23 is $5.05, with a low estimate of $4.91 and a high estimate of $5.37. This represents a 27.14% increase compared to HCA previous annual EPS of $3.97 (Sep 23).
HCA Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CYH | Community Health Systems | $5.70 | $11.00 | 92.98% | Buy |
| SGRY | Surgery Partners | $30.18 | $47.50 | 57.39% | Buy |
| CCRN | Cross Country Healthcare | $13.59 | $21.00 | 54.53% | Buy |
| AMED | Amedisys | $97.17 | $143.38 | 47.56% | Hold |
| ACHC | Acadia Healthcare Company | $76.46 | $84.89 | 11.03% | Buy |
| EHC | Encompass Health | $91.66 | $93.17 | 1.65% | Buy |
| ADUS | Addus HomeCare | $126.37 | $123.00 | -2.67% | Buy |
| UHS | Universal Health Services | $229.15 | $208.47 | -9.02% | Hold |
| FMS | Fresenius Medical Care AG & Co. KGaA | $19.68 | $17.85 | -9.30% | Hold |
| DVA | DaVita | $149.98 | $125.50 | -16.32% | Hold |
| THC | Tenet Healthcare | $153.40 | $124.87 | -18.60% | Buy |
| ENSG | Ensign Group | $149.05 | $114.25 | -23.35% | Buy |
| HCA | HCA Healthcare | $387.98 | $291.95 | -24.75% | Buy |
HCA Forecast FAQ
Is HCA Healthcare a good buy?
Yes, according to 23 Wall Street analysts, HCA Healthcare (HCA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 17 'Buy' recommendations, accounting for 73.91% of HCA's total ratings.
What is HCA's price target?
HCA Healthcare (HCA) average price target is $291.95 with a range of $224 to $430, implying a -24.75% from its last price of $387.98. The data is based on 23 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will HCA Healthcare stock go up soon?
According to Wall Street analysts' prediction for HCA stock, the company can go down by -24.75% (from the last price of $387.98 to the average price target of $291.95), up by 10.83% based on the highest stock price target, and down by -42.27% based on the lowest stock price target.
Can HCA Healthcare stock reach $600?
HCA's average twelve months analyst stock price target of $291.95 does not support the claim that HCA Healthcare can reach $600 in the near future.
What is HCA Healthcare's current price target trend?
1 Wall Street analyst forecast a $430 price target for HCA Healthcare (HCA) this month, up 10.83% from its last price of $387.98. Compared to the last 3 and 12 months, the average price target increased by 3.74% and decreased by -4.29%, respectively.
What are HCA Healthcare's analysts' financial forecasts?
HCA Healthcare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $74.6B (high $75.81B, low $73.58B), average EBITDA is $14.89B (high $15.14B, low $14.69B), average net income is $6.59B (high $6.73B, low $6.47B), average SG&A $34.19B (high $34.75B, low $33.72B), and average EPS is $24.94 (high $25.47, low $24.5). HCA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $78.79B (high $80.07B, low $77.72B), average EBITDA is $15.73B (high $15.99B, low $15.52B), average net income is $7.16B (high $7.31B, low $7.04B), average SG&A $36.11B (high $36.7B, low $35.62B), and average EPS is $27.13 (high $27.7, low $26.65).
Did the HCA's actual financial results beat the analysts' financial forecasts?
Based on HCA Healthcare's last annual report (Dec 2022), the company's revenue was $60.23B, beating the average analysts forecast of $60.1B by 0.21%. Apple's EBITDA was $12.07B, missing the average prediction of $12.87B by -6.23%. The company's net income was $5.64B, missing the average estimation of $5.78B by -2.34%. Apple's SG&A was $27.68B, missing the average forecast of $27.97B by -1.03%. Lastly, the company's EPS was $20.34, beating the average prediction of $16.63 by 22.29%. In terms of the last quarterly report (Sep 2023), HCA Healthcare's revenue was $16.21B, beating the average analysts' forecast of $15.82B by 2.47%. The company's EBITDA was $2.88B, missing the average prediction of $3.16B by -8.83%. HCA Healthcare's net income was $1.08B, beating the average estimation of $1.05B by 2.79%. The company's SG&A was $7.56B, beating the average forecast of $7.25B by 4.20%. Lastly, the company's EPS was $3.97, missing the average prediction of $3.98 by -0.13%